Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

European Animal Tissue Directive.

Maria Donawa1

  • 1donawa@srd.it www.donawa.com

Medical Device Technology
|March 5, 2004
PubMed
Summary

Medical device manufacturers must prepare for new regulations on animal-origin tissues within nine months. Proactive compliance planning is crucial to meet these upcoming specifications for product safety and market access.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

US regulation of combination products.

Medical device technology·2010
Same author

Clinical studies in Italy.

Medical device technology·2010
Same author

Meeting US and European supplier control requirements.

Medical device technology·2009
Same author

Avoiding surprises when implementing a single quality system.

Medical device technology·2009
Same author

Addressing Eeuropean environmental legislation.

Medical device technology·2009
Same author

Addressing US and European device testing requirements.

Medical device technology·2008

Area of Science:

  • Biomedical Engineering
  • Regulatory Affairs
  • Materials Science

Background:

  • Medical devices increasingly utilize tissues of animal origin.
  • New regulatory specifications for these materials are imminent.
  • Compliance timelines present significant challenges for manufacturers.

Purpose of the Study:

  • To outline key considerations for medical device manufacturers regarding new animal-origin tissue specifications.
  • To emphasize the urgency of addressing compliance requirements.
  • To provide a roadmap for effective regulatory adherence.

Main Methods:

  • Review of newly mandated specifications for animal-origin tissues.
  • Analysis of potential compliance challenges for medical device manufacturers.
  • Discussion of critical issues impacting product development and market entry.

Main Results:

  • Manufacturers have a less than nine-month window to achieve compliance.
  • Proactive planning and strategic implementation are essential.
  • Failure to comply may result in market access delays or product recalls.

Conclusions:

  • Immediate action is required by medical device manufacturers.
  • Thorough understanding and preparation for new specifications are vital.
  • Effective compliance strategies will ensure product safety and regulatory adherence.

Related Experiment Videos